Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Peptide
TACSTD2
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits TACSTD2
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- TROP2 peptide corresponds to 14 amino acids of TROP2.
-
Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) peptide
TACSTD2 Reactivité: Humain, Rat, Souris, Porc, Boeuf (Vache), Chien Hôte: Synthetic BP, Imm
-
- Indications d'application
- TROP2 Peptide is used for blocking the activity of TROP2 antibody . The TROP2 antibody ships at 0.5 mg/mL and the TROP2 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- TROP2 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
- Synonymes
- EGP-1 Peptide, EGP1 Peptide, GA733-1 Peptide, GA7331 Peptide, GP50 Peptide, M1S1 Peptide, TROP2 Peptide, C80403 Peptide, Ly97 Peptide, Prp1 Peptide, tumor associated calcium signal transducer 2 Peptide, tumor-associated calcium signal transducer 2 Peptide, TACSTD2 Peptide, Tacstd2 Peptide
- ID gène
- 4070
- NCBI Accession
- NP_002344
- OMIM
- 166795236
- UniProt
- P09758
-
Vous êtes ici:
